BRIDGEBIO PHARMA INC.
26.27
08-November-24 12:22:16
15 minutes delayed
Stocks
+0.39
+1.51%
Today's range
25.57 - 26.42
ISIN
N/A
Source
NASDAQ
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
03 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
18 Jul 2023 07:30:00 By Nasdaq GlobeNewswire
-
17 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
14 Jul 2023 16:01:00 By Nasdaq GlobeNewswire
-
12 Jul 2023 16:31:00 By Nasdaq GlobeNewswire
-
20 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
13 Jun 2023 09:33:35 By Nasdaq GlobeNewswire
-
15 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update
04 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference
27 Apr 2023 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11 Apr 2023 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07 Apr 2023 07:30:00 By Nasdaq GlobeNewswire
-
23 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2023 07:30:00 By Nasdaq GlobeNewswire